DS Oliveira

Hospital Geral de Fortaleza · CE · 19 publicações em 2022–2025

Chronic Lymphocytic Leukemia ResearchAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsRetinoids in leukemia and cellular processesAcute Lymphoblastic Leukemia research

Principais coautores no Nordeste tamanho = publicações em comum

RM Ribeiro LA Gurgel IL Pontes MEA Moraes Caroline Aquino Moreira-Nunes FMCP Pessoa MOM Filho KMC Albuquerque FET Filho IV Barreto CB Machado FAC Silva

Publicações recentes

2025 2

PROGNOSTIC SCORES AND MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKAEMIA: COMPARATIVE ANALYSIS AND PREDICTIVE MODELLING IN A REAL-WORLD COHORT
Medicina · Hematology Transfusion and Cell Therapy
SURVIVAL OUTCOMES AND PROGNOSTIC DETERMINANTS IN CHRONIC MYELOID LEUKAEMIA: ANALYSIS OF RISK SCORES, MOLECULAR RESPONSE, AND TREATMENT DYNAMICS
Medicina · Hematology Transfusion and Cell Therapy

2024 9

IMPACT OF HIGH-RISK CYTOGENETICS ON THE SURVIVAL OF NON-APL ACUTE MYELOID LEUKEMIA PATIENTS
Medicina · Hematology Transfusion and Cell Therapy
QUANTITATIVE RT-QPCR BCR::ABL1 AT DIAGNOSIS OF CHRONIC MYELOID LEUKEMIA: A POPULATIONAL DECAYING ANALYSIS
Medicina · Hematology Transfusion and Cell Therapy
IMPACT OF PRE-TREATMENT TRANSFUSIONS ON CLINICAL PARAMETERS AND OUTCOMES IN APLASTIC ANAEMIA PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY
Medicina · Hematology Transfusion and Cell Therapy
CLINICAL PROFILE AND SURVIVAL IN PATIENTS WITH HIGH-GRADE NON-HODGKIN LYMPHOMA
Medicina · Hematology Transfusion and Cell Therapy
PREDICTIVE VALUE OF QUANTITATIVE RT-QPCR BCR::ABL1 AT DIAGNOSIS AND EUTOS SCORE FOR IMATINIB RESPONSE IN CML PATIENTS
Medicina · Hematology Transfusion and Cell Therapy
EVALUATING TREATMENT TIMELINES AND SURVIVAL OUTCOMES FOR PRIMARY CNS LYMPHOMA: A CROSS-SECTIONAL EVALUATION
Medicina · Hematology Transfusion and Cell Therapy
RISK FACTORS'IMPACT ON THE OVERALL SURVIVAL OF ACUTE LYMPHOBLASTIC LEUKEMIA ADULT PATIENTS IN FORTALEZA
Medicina · Hematology Transfusion and Cell Therapy
CLINICAL HETEROGENEITY AND IMPACT OF TREATMENT INITIATION TIME IN NON-HODGKIN LYMPHOMA
Medicina · Hematology Transfusion and Cell Therapy
CLINICAL CHARACTERISTICS AND PROGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS IN FORTALEZA
Bioquímica, genética e biologia molecular · Hematology Transfusion and Cell Therapy

2023 6

DAUNO 60 OU DAUNO 90? UMA ANÁLISE MATEMÁTICA DO PROBLEMA ATRAVÉS DA INTERPOLAÇÃO DE LAGRANGE EM MODELO LOWESS
Medicina · Hematology Transfusion and Cell Therapy
COMPARAÇÃO ENTRE CHANCE DE SOBREVIDA EM PACIENTES COM LEUCEMIAS AGUDAS E INFECÇÃO/COLONIZAÇÃO POR GRAM-NEGATIVOS MULTIRRESISTENTES
Medicina · Hematology Transfusion and Cell Therapy
QUIMIOTERAPIA DE RESGATE EM PACIENTES COM D14 POSITIVO DE INDUÇÃO DE LEUCEMIA MIELOIDE AGUDA: ANÁLISE DE FATORES QUE PODEM INFLUENCIAR NA DE REMISSÃO COMPLETA
Medicina · Hematology Transfusion and Cell Therapy
VALIDAÇÃO DE GENES DE REFERÊNCIA PARA ESTUDOS DE ANÁLISE DE EXPRESSÃO EM AMOSTRAS DE LEUCEMIA AGUDA
Bioquímica, genética e biologia molecular · Hematology Transfusion and Cell Therapy
CARACTERÍSTICAS EPIDEMIOLÓGICAS DE PACIENTES COLONIZADOS/INFECTADOS POR BACILOS GRAM-NEGATIVOS DURANTE TRATAMENTO QUIMIOTERÁPICO INTENSIVO PARA LEUCEMIA AGUDA
Medicina · Hematology Transfusion and Cell Therapy
COMPARAÇÃO ENTRE CHANCE DE SOBREVIDA EM PACIENTES COM LEUCEMIA MIELOIDE E LINFOBLÁSTICA AGUDAS EM PACIENTES TRATADOS PARA INFECÇÃO FÚNGICA INVASIVA
Medicina · Hematology Transfusion and Cell Therapy

2022 2

EPIDEMIOLOGICAL AND MOLECULAR PROFILE OF PATIENTS WITH ACUTE MIELOID LEUKEMIA IN CEARÁ
Medicina · Hematology Transfusion and Cell Therapy
EPIDEMIOLOGICAL AND MOLECULAR PROFILE OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN CEARÁ
Medicina · Hematology Transfusion and Cell Therapy

Dados obtidos de fontes abertas: OpenAlex (CC0), ROR (CC0), CAPES Dados Abertos (CC-BY), INEP e IBGE. Encontrou um erro sobre você? Saiba mais. Criado por Gabriel Pina.